Molecular immunologyDec 22, 2018

Chemerin-triggered actions of CMKLR1 are controlled by GRK6 and β-arrestin 2 in inflammation-related immune cells

Circadian Biology Weekly Brief ↗PubMed ↗DOI ↗

Updated Mar 19, 2026

Abstract

Activation of the CMKLR1 receptor by chemerin in primary macrophages is regulated by GRK6 and β-arrestin 2.

GRK6 and β-arrestin 2 are implicated in the signaling and functional outcomes of CMKLR1 activation in macrophages.
Co-expression of GRK6 enhances the recruitment of arrestin to CMKLR1 after chemerin stimulation.
Internalization of CMKLR1 in response to chemerin is reduced in inflammatory macrophages lacking GRK6 and β-arrestin 2.
Macrophages deficient in GRK6 and β-arrestin 2 show increased migration towards chemerin.
Alterations in AKT and Extracellular-signal Related Kinase (ERK) signaling are observed in GRK6- and β-arrestin 2-deficient macrophages.

Simplified

Chemerin receptor (CMKLR1) is a G protein-coupled receptor (GPCR) implicated in macrophage-mediated inflammation and in several forms of human arthritis. Analogous to other GPCR, CMKLR1 is likely regulated by G protein-coupled receptor kinase (GRK) phosphorylation of intracellular domains in an activation-dependent manner, which leads to recruitment and termination of intracellular signaling via desensitization and internalization of the receptor. The ubiquitously expressed GRK family members include GRK2, GRK3, GRK5, and GRK6, but it is unknown which GRK regulates CMKLR1 cellular and signaling functions. Our data show that activation of CMKLR1 by chemerin in primary macrophages leads to signaling and functional outcomes that are regulated by GRK6 and β-arrestin 2. We show that arrestin recruitment to CMKLR1 following chemerin stimulation is enhanced with co-expression of GRK6. Further, internalization of endogenous CMKLR1, following the addition of chemerin, is decreased in inflammatory macrophages from GRK6- and β-arrestin 2-deficient mice. These GRK6- and β-arrestin 2-deficient macrophages display increased migration toward chemerin and altered AKT and Extracellular-signal Related Kinase (ERK) signaling. Our findings show that chemerin-activated CMKLR1 regulation in inflammatory macrophages is largely GRK6 and β-arrestin mediated, which may impact innate immunity and have therapeutic implications in rheumatic disease.

Full Text

Full text is available at the source.

View Full Text ↗

Chemerin-triggered actions of CMKLR1 are controlled by GRK6 and β-arrestin 2 in inflammation-related immune cells

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief